Fisher & Paykel Healthcare Corporation Limited Share Price
Equities
FPH
NZFAPE0001S2
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.05 NZD | +0.53% |
|
-1.30% | +61.23% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last hours
Enjoy this offer
* See conditions on site
| Capitalization | 22.3B 13.19B 12.5B 11.63B 10.38B 18.47B 1,115B 20.25B 144B 53.6B 457B 49.54B 48.43B 1,984B | P/E ratio 2025 * |
61.7x | P/E ratio 2026 * | 50.5x |
|---|---|---|---|---|---|
| Enterprise value | 22.24B 13.15B 12.46B 11.59B 10.35B 18.42B 1,112B 20.19B 144B 53.44B 456B 49.39B 48.29B 1,979B | EV / Sales 2025 * |
11.1x | EV / Sales 2026 * | 9.89x |
| Free-Float |
91.76% | Yield 2025 * |
1.13% | Yield 2026 * | 1.37% |
More valuation ratios
* Estimated data
More news
Last Transcript: Fisher & Paykel Healthcare Corporation Limited
More recommendations
More press releases
More news
| 1 day | +0.53% | ||
| 1 week | -1.30% | ||
| 1 month | +5.72% | ||
| 3 months | +6.88% | ||
| 6 months | +28.98% | ||
| Current year | +61.23% |
1 week
36.38
39.21
1 month
35.5139.21
Current year
22.5539.21
1 year
22.5539.21
3 years
18.0239.21
5 years
18.0239.21
10 years
5.5539.21
| Director | Title | Age | Since |
|---|---|---|---|
Lewis Gradon
CEO | Chief Executive Officer | 63 | 31/03/2016 |
Lyndal York
DFI | Director of Finance/CFO | - | 28/02/2019 |
Dexter Cheung
CTO | Chief Tech/Sci/R&D Officer | - | 31/07/2014 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Daniell
BRD | Director/Board Member | 66 | 31/10/2001 |
Lewis Gradon
BRD | Director/Board Member | 63 | 31/03/2016 |
| Director/Board Member | - | 31/05/2017 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.39% | 20 M€ | +15.49% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +0.53% | -1.30% | +61.50% | +14.16% | 13.19B | ||
| -0.15% | +0.86% | +13.88% | -5.57% | 206B | ||
| +0.31% | +0.38% | +9.17% | -18.89% | 111B | ||
| -0.04% | -0.94% | -6.05% | -6.43% | 64.16B | ||
| +0.74% | +2.67% | +23.69% | +117.32% | 48.62B | ||
| -1.21% | -0.59% | +15.57% | +6.88% | 44.52B | ||
| -0.14% | +7.08% | -32.49% | -44.55% | 30.46B | ||
| -0.94% | -0.72% | +29.33% | +31.85% | 30.01B | ||
| +0.73% | +2.87% | -7.15% | -26.43% | 23.59B | ||
| +0.07% | +1.71% | -3.62% | -6.27% | 22.31B | ||
| Average | -0.01% | +1.52% | +10.39% | +6.21% | 59.38B | |
| Weighted average by Cap. | -0.04% | +1.93% | +9.75% | +2.32% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2B 1.18B 1.12B 1.04B 929M 1.65B 99.78B 1.81B 12.88B 4.8B 40.93B 4.43B 4.33B 178B | 2.24B 1.33B 1.26B 1.17B 1.04B 1.86B 112B 2.03B 14.47B 5.39B 45.98B 4.98B 4.87B 199B |
| Net income | 358M 211M 200M 186M 166M 296M 17.88B 325M 2.31B 860M 7.34B 794M 777M 31.82B | 437M 259M 245M 228M 204M 362M 21.87B 397M 2.82B 1.05B 8.97B 972M 950M 38.92B |
| Net Debt | -67M -39.61M -37.54M -34.93M -31.18M -55.49M -3.35B -60.82M -432M -161M -1.37B -149M -145M -5.96B | -127M -74.9M -70.99M -66.04M -58.95M -105M -6.33B -115M -818M -304M -2.6B -281M -275M -11.27B |
More financial data
* Estimated data
Employees
7,005
Calendar
20/05/2025
- Q4 2025 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/11/24 | 38.05 $ | +0.53% | 517,436 |
| 28/11/24 | 37.85 $ | -1.48% | 575,331 |
| 27/11/24 | 38.42 $ | +1.75% | 422,119 |
| 26/11/24 | 37.76 $ | -3.70% | 473,375 |
| 25/11/24 | 39.21 $ | +1.71% | 1,934,021 |
End-of-day quote New Zealand S.E., November 28, 2024
More quotes
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
13
Last Close Price
38.05NZD
Average target price
32.66NZD
Spread / Average Target
-14.16%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- FPH Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition